Companies with strong compliance efforts could create competitive advantage.
Food and Drug Administration (FDA) Commissioner Scott Gottlieb has announced the agency will increase its oversight of dietary supplements, partially in response to the growth of the industry, which has exploded from $4 billion to $40 billion since 1994.
Oversight appears to be on the rise in many areas, and those direct sellers with strong compliance efforts well may gain an advantage in the coming year over those who get snared in both federal and state scrutiny.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.